Tune into Safe Healthcare: Implementation of Priority Core Elements in Critical Access Hospitals

CDC
258 followers
1 Video View·Feb 13, 2025
During this webinar, presenters will outline the requirements for meeting the Antimicrobial Use and Resistance (AUR) Surveillance measure within the Centers for Medicare & Medicaid Services Promoting Interoperability Program (PIP). Presenters will discuss ways health departments can support antibiotic stewardship programs in Critical Access Hospitals and describe Priorities for Hospital Core Element Implementation to inform and implement antibiotic stewardship activities.
This video can also be viewed at
https://www.cdc.gov/infection-control/media/videos/WD4912-Priority-Core-Elements-After-Accreditation-lowres.mp4
good afternoon I would like to welcome
you to our annual CDC federal office of
rural Health policy webinar uh this
presentation comes on the eve of
national rural Health day which is
always observed on the third Thursday in
November and this year we'll be
discussing in our webinar antibiotic
stewardship specifically the
implementation of priority core elements
in critical access hospitals my name is
Kristen Dyan I'm a family physician and
the chief medical officer for the
federal office of rural Health policy
we're one of the bureaus within the
Health Resources Services Administration
um in the federal uh Department of
Health and Human
Services but during the 30 plus years
since Congress has established our
office um we have served the health of
rural Americans in three main ways um
listening to stakeholders we travel
widely for meetings um engagement
sessions uh to hear what's what's
happening in rural communities to learn
about your successes and to also learn
about your needs and the ways that help
could be helpful um we also coordinate
across the agencies within Health and
Human Services and other agencies like
the US Department of Agriculture to
ensure that the work of the federal
government aligns with what rural
communities need and avoids errors that
might be detrimental to your interests
and uh finally we provide grants and
technical assistance um which you can
learn more about on our website or
through our email for announcements um
and today's today's session falls into a
couple of those areas but especially
coordinating um with our colleagues at
the centers for Centers for Disease
Control and prevention CDC um and also
um our technical assistance that we
provide to Inc improve the quality and
safety of the health care available to
rural Americans so thank you so much for
attending today please um do your part
to celebrate rural Health rural
Healthcare Providers tomorrow on Rural
Health day and I'm going to hand it over
to my colleague Melinda newuser from
CDC thank you
Kristen my name is Melinda newuser and I
am a pharmacist and acute care lead for
the office of antibiotic stewardship and
I'll be the moderator today uh before we
begin I have several disclosure slides
related to the CE that is being offered
through cdc's train Learning Network
we'll Advance through them slowly so you
have time to read
this first one is for the continuing
education accreditation statement and
the webinar is accredited for the
following
cus they include CME C NE
ceu
cesm
CES CP and
cph I'll now show with you the following
disclosure statement please take a a
minute to
read and this is the joint accreditation
statement for pharmacy education again
just take a minute minute to read and
this will be the last of the C
disclosure
slides okay I think we
can transition to the fun part uh this
year's webinar is in held in celebration
of course um for National World Health
day uh as Kristen already mentioned but
also for us antibiotic awareness week
and we have several incredible
speakers uh first is Amy who will
provide a brief overview of the Cass
promoting inter our operability program
and Aur and then I'll discuss the CC
these priority core elements Anthony
will be discussing implementing the
priority core elements in the critical
access hospitals and then finally Trevor
will be presenting on Health Department
support for stewardship and critical
access hospitals and then each speaker
will more formally introduce themselves
and their roles at the beginning of
their presentation and then as time
permits Will Follow by a Q&A at the end
next slide
thanks Melinda so hi everyone thanks for
joining today's webinar my name is Amy
web I am a senior Public Health analyst
with the nhsn or national healthc care
safety Network and a microbial use and
resistance team so my uh me and my team
uh do all sorts of educational um types
of trainings we maintain the nhsn
application and um as always answer all
your questions that come into the nhsn
mailbox so today I'm going to first
cover the Medicare promoting probability
program as well as um how that changes
how those changes for 2025 affect your
Aur module submissions so next slide
please okay and a disclaimer here so the
slides uh and my answers to any
questions that come into the Q&A box are
going to be based off of the final rule
that CMS published a few months ago now
the link here is at this uh the link
here is on the slide as you can see they
also published a fact sheet which is a a
much smaller version of the changes in
the rule next slide
please so as you hopefully know for
calendar year 2024 this was the first
year that CMS required or had a required
measure for a reporting in the CMS
promoting operability program so the pi
program requires eligible hospitals and
critical access hospitals to to report
on specific objectives and measures to
be considered a meaningful EHR user and
Facilities could um need to report in
order to avoid a downward payment
adjustment so there are many other parts
of the pi program uh I'll abbreviate
proability to the pi program in my in my
slides today um but as you can see in
the screenshot on the slide Aur is just
a tiny piece of that program this
program has been in existence for many
years and was previously known as the
meaningful use program 24 is just the
first year where a is
required next slide
please so as a reminder uh we get this
question a lot whether your facility is
eligible to participate most likely it
is we if you are not sure please reach
out to the folks that are in charge of
Quality Reporting in your facility and
or the sea Suite folks since there is
payment associated with participation in
this program but as you can see in the
uh towards the top left of this
uh table here eligible facilities
include acute care hospitals and
critical access hospitals that are
eligible for the pi program and eligible
to report a data to
HSN the handful of facilities that are
not eligible for the pi program include
impatient rehab impatient psych
long-term acute care hospitals and Rural
emergency hospitals so if any rural
emergency hospitals are out there
listening today you do not participate
in the p Pi program and therefore are
not required to report a module data to
nhsn next slide
please so we've already kind of covered
this the a module data or participation
in the Aur module are required for this
calendar year 2024 and again that
applies to eligible hospitals and
critical access hospitals and the
measure includes submission of both Au
and a option data so for this calendar
year 2024 facilities have to be
attesting to either being an active
engagement to submit a data or claim an
applicable
exclusion next slide
please so if you're not familiar with
the term active engagement that's used
throughout the cmspi program so you have
these two options option one which is
kind of the first level if you will
pre-production
validation that includes registration
within an inen that's just a onetime uh
one-step process then the facility Works
toward towards uh the testing and
validation of their CDA files with their
vendor so CMS clarified that in order to
attest option one you just need to
register and then work towards the
generation of those test files in this
calendar year to be able to attest to
option one you don't actually have to
complete that test file step uh for
option
one if you're further along in the
process maybe you're going going to
attest to option two validated data
production so again those folks still
need to complete that registration
screen but then they move on to
submitting production Au and AR option
data into NH HSN during their EHR
reporting period which for calendar year
2024 is a period of 180 continuous
calendar
days next slide
please so we have three exclusions for
2024 so number one does not have any
patience in the patient care locations
for which data are collected during that
180-day EHR reporting period so that
might be if your facility was closed um
due to a natural disaster or large scale
construction per se maybe um that would
be exclusion number one number two does
not have the electronic medication
administration record or the barcoding
medication administration system or
electronic ADT system and that would
meet criteria number two and lastly uh
number three does not have the
electronic Lis system or electronic ADT
system that would meet criteria number
four and more specifically that is um
number three is probably the most common
exclusion we're seeing or we're hearing
from facilities about and that's
specifically related to if you send out
your isolates for either species
identification or and microbial
susceptibility testing and those results
come back to you in the form of a PDF or
maybe even a fax those data that are
coming back to you are not interoperable
and therefore you would need to claim
this number three exclusion
next slide
please okay so let's talk through some
exclusion examples for 2024 so for
number one let's say we're going to use
Canada because Canada is the most
frequent organism we hear about for
exclusion purposes so if your Canada
isolates are sent out for identification
or a and return to the facility via PDF
or fax then again like we've just
covered you don't have interoperable
data and you should claim the
exclusion however number two if your
candidate isolates cannot be speciated
and then those isolates are not eligible
for AR option reporting because for 2024
we require um specific Canada species to
be reported so if you don't have that
information you don't have species
information you don't have the data for
Canada so you would not report any
Canada and you would also not claim a pi
exclusion and then exclusion or example
number three if Canada isolates are
speciated but do not have as performed
then also those isolates are not
eligible for error reporting since in
2024 we require all isolates to have
antimicrobial susceptibility testing to
be considered an eligible isolate so in
that case again you don't have the data
that would be needed for submitting
Canada so you would not claim the pi
exclusion in in that case
either next slide
please okay so now that we've covered an
overview of 2024 let's jump into what's
changing for calendar year
2025 so this slide highlights the three
big changes that we'll talk through in
more detail in the future slides but
also you can see um in the screenshot on
the slide the new measures or the
separated measures for calendar year
20125 so the a measure is being split
into two separate measures Au
surveillance and a
surveillance because of that because of
the split they are both be being
considered brand new measures by CMS for
2025 which means facilities have an
extra year in option year one if you
need it for
2025 and also the exclusions have now
been separated and one new exclusion has
been added for each measure next slide
please okay so the split of au and AR
into two separate measures means that
your hospital has to be an active
engagement or have an applicable
exclusion for each measure because both
are still required for the pi program
for
2025 so as an example for
2024 if for example your facility met
that exclusion where you don't have
interoperable data coming back to you
from your external lab you could claim
the exclusion based on your AR data
which would also allow you to not report
Au data to nhsn because they're a single
measure and claiming an exclusion uh for
AR also kind of carries over into
Au however for 2025 because of the split
you have to have them think of them in
as two separate measures essentially so
let's talk through some examples here so
example one the hospital can attest to
option two for Au surveillance maybe
they're already submitting Au
surveillance and have been Au data and
have been for some time while also
attesting to option one for AR
surveillance perhaps they're just
getting their data feeds set up with
their vendors or doing some validation
they would be an option one for
AR or example two maybe you're starting
out um from a more beginner level for Au
and you're going to attest to option one
you're still getting things up and
running for Au while maybe you're going
to claim an exclusion for AR all this is
to say that if you claim an exclusion
for AR it doesn't automatically give you
an exclusion for Au in 2025 you have to
report or have an au specific
exclusion next slide
please so with the split the Au and AR
measures are considered two separate
measures which essentially allows you at
your hospitals to spend an extra year in
calendar in calendar 2025 in option one
the pre-production and testing before
moving to option two for 2026 so if
you're out there now and you're planning
to claim or attest to option one for
calendar year 2024 for the Aur
surveillance combined measure you could
still if it was if it's reflecting your
accurate status for 2025 attest to
option one for both Au and AR for your
2025 active engagement status as
well next slide
please okay so let's step through the
exclusions so for the Au surveillance
measure we have three exclusions you can
see that number one and number two are a
direct match to the 2024 exclusions and
number three here is the new one does
not have the data source containing the
minimal discret data elements that are
required for reporting uh so that is a
brand new exclusion specifically for
calendar year 2024 calendar year 2025
excuse me and forward next slide
please and for AR surveillance you can
see here that number one and number two
map to the previous exclusions for 2025
exactly and number three again is the
brand new one it's actually the same
wording as the new one for the Au
surveillance measure and essentially
gets towards that does not have the
minimal discrete data elements um so in
the example where you send out your
isolates and they come back to you via
PDF you would claim this number three
exemption or exclusion excuse me for
calendar year
2025 next slide please okay so let's
talk through those same exclusion
examples just in the lens of
2025 so example number one you send out
your canidate isolates and they return
via PDF or facts again you still don't
have that interoperable data and you
would claim that number three exclusion
on the previous
slide and number two and number three
examples are actually a a little bit of
a spoiler to some changes we have coming
up in my next few slides I'll talk about
for AR option reporting but uh in
2025 the AR option is going to expand to
include all Canada genus level codes and
species or the one Canada genus code and
all Canada species so in example two if
your Canada isolates cannot be speciated
that's okay for 2025 because you can
report Canada genus as the code in that
AR event so in that case you would not
claim the exclusion and you would submit
your AR events using the Canada genus
code um for the organism code in that
case and number three if you're Canada
are speciated but do not have a
performed uh again they are now eligible
for reporting in 2025 we're making
essentially an exception uh we heard a
lot from facilities that either they
don't do a at all on their Canada
isolates or only at physici request um
only in specific scenarios so we are
expanding the AR option to include
Canada isolates without antimicrobial
susceptibility testing so if that's the
case for your hospital then those
isolates become eligible
in 2025 as AR events and you would not
claim an
exclusion next slide
please okay but remember you have to
have an exclusion for each measure
separately because they're two separate
measures so let's say example number one
if your hospital impatient units were
closed for construction you could claim
an exclusion for both Au and AR
surveillance measures because that
number one exclusion on both Au and AR
was valid
or in example number two let's say your
hospital does not receive those a
results from your external lab in
discrete Fields you could claim
exclusion three for a surveillance but
you must be an active engagement to
report your a data if you didn't have
anything that met an au
exclusion next slide
please okay so now as far as what to do
in 20125 the steps are still the same so
if your hospital has not already
registered intent in the vast majority
of you have already done that step then
no further um registration is required
you can only do that step one time you
won't ever do it again if your hospital
has already sent test files and many of
you have already done that so if you've
already done that this year or any
previous calendar year you don't need to
resend those so if your hospital is
already sending production data you
would continue sending production data
so nothing really changes so depending
on what part you're at in the process
you just continue on the process just as
you were planning to essentially when
the measures were combined next slide
please and the same deadlines will apply
in calendar your 2025 so registration if
you haven't already done that you you're
planning to do that in 2025 CMS uh
states that you should register your
intent within 60 days of the start of
your 180-day reporting
period those test files if you haven't
already sent those and you plan to do
that step we um ask that reply to our
request for test files within 60 days of
that request just to show that you're
actively engaged with us you're um
you're replying to the email essentially
but if your test files are not ready yet
that's okay you just send a status
update that says you know I'm working on
XYZ and we hope to have the test files
ready you know within the next three
months or something like that that's all
you need and no further status updates
are needed after that but if you'd like
the official letter that says you've
pass that test file step in calendar
year 2025 then we ask that you send
those test files to us no later than
November 1st
2025 and lastly if you're sending
production data you'll continue to
report your production data on an
ongoing
basis next slide
please okay so now let's pivot just a
little bit and talk through some of the
changes that are coming up for the Aur
module in calendar year
2025 next
slide so for the Au option the changes
are very minimal we are adding these
three new drugs that were uh newly FDA
approved during this last calendar year
and we were removing just one drug this
year chor pentacol these are effective
as of January 2025 so the files that
you're submitting to nhsn in for January
2025 and forward must reflect the three
new drugs and the one drug removed and
we've shared all this information with
your software vendors already so they
should be well aware of what changes
need to be made next slide
please now the rest of it is um changes
for the AR option so for pathogens for
the AR pathogen we're adding group a
streptococus as an eligible organism and
we are expanding to genus and all
species level codes for Canada like
we've already discussed Citra actor
Proteus and
clella and we plan to refresh the a
option path engine rollup workbook to
help you uh navigate the the different
um snow Med codes that could be produced
by your
lab next slide
please we are adding a whole new
specimen source group so we're adding
skin soft tissue wound and muscular
skeletal groups um we are they will the
cdc's AR threats report will eventually
be compiled using AR data air option
data for specific pathogens um and
therefore to align with the criteria
that they have used in previous threats
report uh we need to to expand our
specimen sources so we're doing that for
20125 and then we're also adding IND
indwelling catheter specimen back to the
list that was mistakenly removed last
year I believe so that's the update to
specimen sources next slide
please and then as far as antimicrobial
susceptibility testing we actually
updated all of our drug panels uh to
reflect updated clsi testing
recommendation patients and we we will
be updating the nhsn AR option phenotype
definitions
accordingly the group a streptococus
will share a panel a drug panel with
Group B streptococus we're adding a
urine panel for pomonis ofosa and as
we've previously discussed Canada
isolates will be the only organisms that
can be reported as an eligible AR event
without antimicrobial susceptibility
testing
performed next slide please
so this slide shows at a high level the
the criteria for what will be eligible
events come 2025 so as you remember the
AR events are isolate level
susceptibility results for specific
organisms so in order to qualify as an
eligible event the isolet must be
collected in an eligible location or
unit collected from now one of eight
specimen sources so in the in the figure
here you can see the new box for skin
soft tissue wound and muscular skeletal
has to have an eligible organism
identified and as must be completed
however with the exception of Canada
isets and the isolet qualifies for
submission regardless of the results so
even if all the drugs uh that were
tested were susceptible that still
qualifies as an AR event next slide
please and then we made a few updates um
to some other definitions so in the
denominators we clarified the definition
to match the Au option we updated the
encounter definition to essentially make
it a little bit easier to be captured in
some vendor systems essentially the
patient can contribute an encounter as
soon as they had an initial interaction
with a medical professional so at the
beginning of triage for
example and then we've updated our
admission status definition as well to
indicate that um what should happen if
the patient was transferred to another
facility and they had a specimen
collected in your emergency room for
example so that definition has also been
updated next slide
please that concludes my section of the
presentation and I'll pass it over to my
colleague
Melinda great thank you Amy I'll provide
a brief overview of the priorities of
Hospital core element
implementation next
slide uh but first we're going to just
set the stage and that improving
antibiotic use and implementing
antibiotic stewardship activities is a
core strategy to improve patient safety
and combat the threat of antimicrobial
resistance the main guidance to improve
antibiotic use across the healthc care
settings is through the framework of the
core elements make most of you are
familiar with the hospital core Elements
shown on the screen that were released
in
2014 and then updated in 2019 and
outlined the structural and the
procedural components that are
associated with a successful stewardship
program next
slide since their release the CDC has
been tracking the number and percent of
hospitals meeting all seven core
elements reported this is self-reported
to the nhsn annual Hospital survey
yearly you can see that when we started
in 2014 the uptake was less than 50% of
hospitals in 2023 nearly 90% of over
5,000 us hospitals had an otic
stewardship programs that met all seven
core elements next
Slide the critical access hospitals also
show a very similar increase in uptake
of the core elements with nearly
92% of all cause meeting all seven core
elements in
2023 next
slide with such robust uptake of the
hospital core elements the CDC released
the priorities of Hospital core element
implementation
which we often call prity Core elements
that can help enhance the quality and
impact of the existing antibiotic
stewardship programs it's important to
note that the priorities do not replace
the hospital core elements but are
consider a supplemental guidance next
Slide the priorities are derived from
the hospital core elements and they
highlight a subset of effective
stewardship implement approaches that
are supported by the evidence or
recommended by stewardship experts and
they provide Hospital leadership and
antibiotic stewards opportunity to
expand their Hospital programs this is a
screenshot of the chart comparing the
core elements and the priorities that
are posted on the website and our next
speaker Anthony will also be
highlighting uh these core elements and
the priority core elements next slide
although at this time less than 15% of
hospitals meet all six of the priority
elements about half of the hospitals
already meet four or five of the
priority elements in
2023 and by highlighting these effective
stewardship activities we anticipate
that priority uptake will increase in
the upcoming 3 to 5
years next
slide in fact uh we actually are already
seeing an increase in the uptake of the
priority car elements this year since we
released them in the fall of 2022 the
uptake of every one of the priority car
elements has increased by at least a few
percentage points and the largest was
seen in tracking uh largely probably due
to the CMS interoperability requirements
for Aur that Amy just reviewed and
opportunities for improving the uptake
of reporting still exist these should
improve with increased Au data and
additional stewardship implementation
activi ities next
slide and at this time I'm thrilled for
Anthony to uh describe the uptake of
priority core elements in a critical
access hospital that he is a director
pharmacy at Anthony I'll pass it to you
thank you Melinda um as Melinda stated
my name is Anthony rhal I am the
director of um pharmacy at Community
Hospital it's located in Southwest
Nebraska um if you want to go to the
next
slide uh I would like begin just by um
thanking the federal office of rural
Health policy and the CDC for the
opportunity to speak today this is an
honor for me and I am grateful for the
privilege of being able to share with
other critical access hospitals the
steps that Community Hospital has taken
to implement these priorities I hope
other cause out there that haven't yet
done so will be encouraged that this is
not only doable but will benefit their
patients next
slide so I found it interesting that in
Nebraska anyway more facilities both
large and small report that they have
some level of ID specialty training
compared to having ASP responsibilities
built into their job descriptions I
can't exactly say why this is as I feel
a job description is loow hanging
fruit um however I can't overstress how
important implementing this priority is
to the success of your program doing so
sets clear expectations I've provided
some example job descriptions here but
where you really mature is by aligning
these with the annual performance
appraisals the priority does state job
description or performance appraisal or
review but these really go hand inand
and in my opinion are only fully
effective when aligned um in addition I
found it invaluable to incorporate ASP
goals into each annual performance
appraisal so for example for yourself
and staff if applicable start by setting
a goal to obtain ID specialty training
and education next
Slide the next priority can be
particularly challenging for some of the
smaller facilities out there and in some
cases May simply not be feasible the CDC
recognizes this and states that
co-leadership would not be possible for
those cause that do not have pharmacists
on staff out of the 49 smaller
facilities in my state of Nebraska that
responded to the 2023 nhsn survey only
31% have been able to impl mement
this however in a sense this was the
opposite challenge at our facility as we
have adequate Pharmacy staff but we
don't employ our providers it wasn't
actually until fairly recently that one
of our local providers accepted
responsibility for co-leading the
program so in lie of that what we did
early on was to seek out off-site
expertise and support next
slide we've been offended tremendously
in a number of ways for doing so and i'
i' like to highlight some of those
benefits on this next slide provide some
context though first my facility formed
a partnership with Nebraska medicine
beginning in 2020 in order that they
could help us build an effective
stewardship program and though they
support us in a number of ways probably
the most impactful is through a daily
call that my Pharmacy staff have with
their ID staff to review and discuss
patient cases and then that feedback is
passed back on to our local providers
our providers have come to expect this
and I dare say look forward to getting
this feedback because they have learned
from it and have seen their patients
benefit it's actually fairly often that
a provider will approach us before the
call to make sure we will be discussing
their patient I think what really got us
off on the right foot though was framing
this partnership as an opportunity for
our patients to have a free ID consult
so to speak which helped with provider
Buy in from the
start next
slide so this next slide provides a half
dozen links for resources that are
available to be able to complete the
stewardship training that priority 3 is
focused on for those facilities that
haven't accomplished this yet just know
that this doesn't mean you have to hire
an ID provider or have your pharmacist
apply for an ID residency or anything of
the sort these offerings are very doable
as most are online and self-paced I
would also note that the CDC courses
mentioned here are available for no cost
at my facility it is an expectation that
each pharmacist aains at a minimum sidp
training
certification as mentioned previously we
made sure that goal was incorporated
into an annual performance
appraisal I think it is important to
note that in cause most of this training
is falling to the Pharmacists and
although that would technically fulfill
the priority I can't emphasize enough
how important it is for the
effectiveness of your program that you
have physician leadership on your team
and that training occurs for them also
so we've tried to accomplish this a
couple of different ways one simple way
was to carve out some time at our ASP
meetings to watch training videos which
we did with the CDC courses this is
especially effective if your facility
doesn't employ their providers like ours
as it is challenging to get them to
pursue ASP training on their own time
the providers on our team appreciated
not having that additional burden by
instead including that training into the
meetings that they were already
attending even if you only have one or
two providers as members of your ASB
team if you can provide them with some
sort of formal training it will help to
make your ASP efforts more meaningful to
them and there's a good chance that any
change in prescribing practices on their
part will permeate out to the other
providers that are not on the
team next
slide so the next priority has two parts
the first is adopting facility specific
treatment recommendations for common
clinical conditions and the second is
performing prospective audit and
feedback so starting with the facility
specific treatment recommendations
these are foundational and I would
suggest should be one of the first tasks
for an asp team to tackle facilities
should create and Implement order sets
that provide guidance for common
clinical conditions in order to ensure
that prescribing is appropriate targeted
and effective ASP team should also be
reviewing these annually to make sure
the that they are consistent with the
current
recommendations I've listed out several
resources that can be helpful to teams
trying to develop order sets some of
these are free resources that are
available an example is the link I
provided to Nebraska medicines
antimicrobial stewardship programs
clinical pathways and guidance website
which is excellent I've also included a
link to the class research site where
they highlight a number of subscription
services that are available that may be
helpful um thirdly most cause have a
formal relationship with a larger
facility that would be able to support
them in developing any new order
sets whatever way you choose it is
essential to mention however that
although these resources are available
to help they should never just be copied
um it is probably obvious that local
formularies need to be considered but
facilities also must take into account
local susceptibilities when creating and
reviewing antibiotic driven order sets
next
slide moving on to perspective audit and
feedback um I'd have to say it is when
we started doing this that I felt like
we were really truly doing stewardship
it's not that all the things I mentioned
before weren't stewardship or aren't
important um because they are but when
you start making interventions guiding
current antibiotic treatment plans you
have that direct tangible impact on the
quality of care that is being provided
even if your team has rolled out what is
felt to be the best order sets they
simply cannot be sufficient for every
clinical situation you will find that
when you start prospectively auditing
orders there will be a lot of
opportunities for more judicious and
appropriate antibiotic
usage as already mentioned this is where
we found it so invalu able to seek out
remote
expertise I can't stress it enough and I
hope to encourage other cause to
consider doing the same especially if
you're like us or the audit and feedback
responsibilities are going to be
performed by
pharmacists approaching a provider with
unsolicited advice which is part of
providing concurrent audit and feedback
can be daunting but I have seen my staff
develop greater confidence and there is
the weight of the ID experts at Nebraska
medicine to support us with the um
backing that advice
so this slide shows the contract
language that we have in place with
Nebraska medicine to support us with the
daily perspective audit and feedback it
was from one of our daily calls that I
would like to present a case quickly um
from this past summer that I think
illustrates the improved quality of care
that results from such a partnership
next
slide so we had a 60-year-old male
present to our ER upon referral from the
primary care clinic for further
evaluation of an ongoing fever and
altered mental status time six days
although the patient was not
experiencing chest pain shortness of
breath or urinary symptoms the patient
was started on zosin and admitted to the
hospital with a working diagnosis of
pneumonia and possible
UTI next
slide over the next three days the
Patient continued to run high fevers and
worsen clinically in spite of the
absence of lucyisanerd
pharmacist was presenting the case on
the daily stewardship call they asked if
the patient's illness could be tied to
his summer occupation which they
happened to know was lawn mowing the ID
physician on the call that day said it
perhaps could be if the patient happened
to have mowed over a dead rabbit so
after the call the pharmacist
interviewed the patient and discovered
that he had in fact mowed over a dead
rabbit early in the day he started
getting sick the pharmacist discussed
the possibility of t lmia with the
primary care provider who agreed to
perform a tmia workup and switched
antibiotics to an empiric regimen to
cover next
Slide the patient improved rapidly after
switching antibiotic therapy therapy and
it was eventually confirmed to be a case
of tmia but what I really want to call
attention to is that there is a very
high likelihood that we would have
transferred this patient to a higher
level of care if one the pharmacist
didn't know the patient and question if
his summer occupation might be an
environmental cause for his illness
and two the suspicion for Taria hadn't
been raised on the stewardship call
based on that discussion as they were
talking about transferring that patient
that day ultimately because of the
partnership that we have with the
expertise available at Nebraska medicine
we were able to save that patient the
burden of traveling to another facility
hundreds of miles away along with
Associated costs and possible additional
delays and diagnosis next
slide so the fifth priority is
submitting antibiotic use data to nhsn
um and if I'm honest when I saw the
uptake in facilities in Nebraska being
able to meet this I was impressed
particularly considering the number of
cause this includes this slide reflects
this increase over the past couple of
years if you move to the next slide
please this slide shows a state-to-state
comparison um it should be noted those
states with lower submission rates also
tend to have a higher proportion of
cause or cric access hospitals next
slide so this priority can be very
difficult for critical access hospitals
submitting data especially for smaller
facilities may require purchasing
software that is able to package the
data for submission and many of these
Solutions can be quite expensive I think
it's safe to say the addition of au
reporting to the cmspi program as talked
about earlier has contributed to the
uptaken reporting but this nonetheless
remains challenging for those smaller
facilities if purchasing software is
necessary I would encourage facilities
to reach out to their State Health
departments and inquire if they're able
to provide support for Au
reporting I know of at least one state
that is providing expense reimbursement
opportunities to help facilities offset
some of these costs I understand that
there may be some other states that are
doing the same so it's worth reaching
out to see if that's the case despite
the challenges of au reporting it has
been proven to be beneficial to us in
our case because of our reporting the
health department was able to to
identify outliers and prescribing
patterns and provide us with suggestions
for improvement and this benchmarking
will only improve as more facilities
adopt
reporting next
slide however benchmarking and
identified opportunities for improvement
in prescribing mean nothing if you can't
put this data in front of your
prescribers so we run our Aur reports up
through several committees at our
hospital but it's equally important that
your prescribers are given feedback on
how they compare to their appears in
addition to antibiotic prescribing
comparison reports we also track our
intervention acceptance rates which you
see here the example provided on this
slide is at the dashboard level but we
also break this down to the individual
prescriber level and both the
comparative antibiotic prescribing
reports and the intervention acceptance
reports are provided to our providers
annually the simplest way we found to do
this was to incorporate these feedback
reports into periodic performance review
um also known as ope reporting
requirements um but you may find some
other formal means of doing
so um next
slide so I'd like to wrap up by sharing
an example of a quality board that we
published highlighting our stewardship
efforts and accomplishments which we
displayed in the lobby of our front
entrance as one means to raise awareness
of the importance of antimicrob
stewardship and although there is no
priority um for education I believe when
you've put in the effort to implement
the priorities spoken about today and
can then use those tracking elements to
show improvements it provides an
opportunity to send a powerful message
to Providers staff and the public about
the benefits of being good stewards of
our animic
resources and so with that I'm G to hand
it over to Dr Van scabal thank
you thanks Anthony I'm Trevor van scal
I'm an adult infectious phys disease
physician at the University of Nebraska
Medical Center Nebraska medicine I'm
also the medical director for our state
and a microbial stewardship outreach
program I'm going to talk about health
department support for stewardship and
critical access hospitals next
slide uh I'm going to couch this in the
core elements for stewardship for health
departments that have recently been
published by the CDC uh in this they
make an argument for why Health
departments are important and I think
Health departments can play an important
role in promoting stewardship Health
departments are uniquely positioned to
engage various Partners be these uh
large organizations be these other um
entities be these payers uh they can
connect with diverse Partners they're
not restricted uh to specific settings
they can collect and Report unique data
particularly through nhsn I'm going to
show you some examples of this and they
can help promote change whether it's
through collaboratives education uh or
even legislation at times and
regulations
next
slide a little bit about our program uh
Health Department stewardship programs
exist at various levels in different uh
regions ours exists at the state level
and as part of the Department of Health
and Human Services the other thing that
know about our program is a little bit
about our state the little orange blobs
are the only nonrural portions of our
state and so we are a decidedly rural
State and so our efforts have focused uh
in those areas of of me next
slide uh the first element is dedicate
human and Financial Resources uh and
that really is the the Health
Department's job is to make sure that
there's someone who makes sure that
Health that these stewardship programs
have adequate Staffing and resources as
well as training and stewardship also
they can help to integrate them into
other structures in the health
department I think infection control and
outbreak uh uh work is particularly
important our program is inte ated with
our state's infection control program um
because there's often great overlap
between those two things they can also
help facilitate collaboration with other
agencies within the within the uh
organization next
slide core elements two and three I've
combined it's designating a leader or
co-leaders physician and a pharmacist
responsible for that program and then
ensuring those leaders have expertise
and experience next slide
so those leaders really are accountable
for the development implementation
planning evaluation reporting everything
related to that stship program the most
important thing that those leaders need
is dedicated time because all of this
work if there's one thing we've learned
all this work of pulling people together
and helping things to happen takes it
just takes a lot of time next
slide also you need to make sure there's
expertise uh whether it's infectious
disease microbiology epidemiology it
communication Grant support it's that
usually means a team but the leaders
really I think need some expertise in
stewardship implementation preferably in
diverse situations because the Health
Department's goal is to promote
stewardship not just in hospitals but
also in smaller hospitals critical
access long-term care ambulatory
settings and every setting that they can
touch next
slide I'll tell you a little bit about
our program the Nebraska antimicrobial
stewardship assessment and promotion
program or the ASAP program uh it's
headquartered at Nebraska medicine UNMC
and it's supported by uh the Department
of Health and Human Services through a
CDC Grant and so we did that partnership
uh for a very specific reason because it
helps us to um have some Cross coverage
and also employ a variety of experts um
which do more than just uh work for our
state institution it's really been a
fantastic partnership we've really
enjoyed the opportunity to work with the
state they've been a great partner uh
and hopefully we've been able to provide
some great partnership for them we
employ ID pharmacists Physicians uh
because we overlap with our infection
control program we share data analyst
administrative assistance and our goal
is to promote the effective use of
antimicrobials and improve patient
outcomes and it's really through
collaboration we're not going to be
stewards for people we want to train and
raise up awesome stewardship programs
all across our state in a variety of
settings next
slide this is our team Dr ashhra is
actually our hii director for the state
and then myself Dr Tron and Dr K
participate in our state stewardship
program Jenna preser is our primary
stewardship pharmacist and it is
responsible for much of the Fantastic
things we do we have a couple other
pharmacists who also help help out and
Danny schroer and Scott Bergman next
slide action uh we need to do something
that is always a part of a stewardship
program we need to do something and the
goal of a health department is really to
support other people doing something and
to do that you have to have a plan uh of
what are we going to do and how are we
going to do it and you need to know who
is available to help and how can they
help in the task and then the key thing
is I think prioritizing to areas where
there's a lack of stewardship expertise
our large hospitals with numerous
infectious disease programs and advanced
stewardship programs usually don't need
need that much help and aren't looking
for help with their sture program in our
state because of the rural nature there
are only two infectious disease
Physicians west of Lincoln Nebraska and
so that means there's a good 400 miles
of the state with very limited access to
infectious disease expertise and so we
have the opportunity to help supplement
that there's other ways you can do you
can provide action you can provide
technical assistant particular with
program development and troubleshooting
you can develop collaboratives those are
always who who you're going to engage
what are you going to do uh and then
there's opportuni to develop guidance
policies tools for facilities to use
lots of things that can be done next
slide some of the things we've done I'll
just outline the first thing that we
started doing as a stewardship outreach
program were stewardship program
assessments and the goal of this is to
evaluate a facility stewardship program
and provide feedback on ways they can
improve particularly as related to the
core elements the way this works as any
Hospital long-term care or outpatient
facility that wants a wants an
assessment fills out a form these uh
it's a structured question set based on
the CDC core elements it doesn't take
very long to fill out once that's
complete we set up a zoom meeting where
we spend about an hour meeting with the
facility stewardship team and we really
want the whole team there because we
take a deep dive into what is their team
do who's part of their team how are they
doing it how effective are they and then
we give some immediate feedback based on
that hourlong report but the hourlong
interview but the big thing we do is we
develop a specific report we can go to
the next slide where we give them tiered
recommendations based on the CDC core
elements and we'll assess that facility
as to how they're doing based on the CDC
core elements next
slide and this is an example of what
they might get where they will'll tell
them where they're meeting where they're
not meeting and then we'll give them
tiered recommendations based on those to
meet those criteria and like uh some of
the exams will be there's no physician
leader if you don't have a physician
leader you're not going to meet the
accountability core element and so to
become become compliant with what CMS
would expect what uh CDC would recommend
as a best practice you need to figure
out who's going to be your physician
leader there's no education so we need
to develop some some plan for education
and then we'll usually have some second
tier recommendations for things that
facilities can do to address specific
issues or improve specific areas but
those tier ones are really focused on
getting in compliant with the CDC core
element and we've done uh many score of
these both in acute care and long-term
care
facilities next
slide this is a a paper we published uh
this last this year uh where we assessed
21 critical access hospitals in uh not
just Nebraska but Iowa as well as we did
some work with them uh this highlights
where facilities met partially met or
didn't meet what you can see is
accountability and education are two
areas where critical acccess hospitals
often struggled to meet the core element
every facility we talked to is doing
something to intervene to improve
antibiotic use uh but we identified
these opportunities uh which are
somewhat in line with what's seen in the
nhsn data next
slide tracking and Reporting Anthony did
a great job talking about this and we've
talked a lot about this in the first
part uh it's important for health
departments to monitor stewardship
activities uh that can be monitoring
core Elements which are what states are
doing through nhsn data or monitoring
outcomes like antibiotic use data and
then use those to identify opportunities
for action and then it is important that
that get reported both departmentally
and back to lower uh local partners and
I'll show you how we've done that next
slide so these are the priority core
elements for critical excess hospitals
in Nebraska and Anthony reference some
of this data uh what we found is that
critical access hospitals are less
likely to have implemented these core
these priority core elements and so one
of our focus is trying to support uh
improving those priority core elements
in critical access hospitals next
slide a big area is in reporting and uh
if Jenna were talking she talk about the
many many many many many hours she's
done supporting what we talked about at
the beginning of this uh seminar is EHR
implementation of this nhsn reporting
we've hosted software vendor uh demos
we've done tons of Education with
facility as to the requirements as to
implementation timelines once facilities
actually start doing this we spend a
bunch of time with nhsn setup location
mapping helping pharmacists figure out
how to be nhsn users because they've not
generally been in the past and then
we've actually spent a significant
amount of time talking to critical
access Hospital administration because
they're the ones who need to understand
what the requirements are what the
software needs are because they're the
ones who usually have to allocate the
funding to implement the software
solutions to accomplish these next
slide uh and what this allowed us to do
is to improve our reporting in 2022 we
had one critical access Hospital
reporting and uh you heard from that
hospital uh but and I think this date is
even a little out of date as as of
September 2024 we had 31 facilities
reporting Au data and 22 reporting AR
data and it's really contributed to a
huge increase in our state Aur reporting
next
slide it's also allowed us to do some
unique things with feedback to our our
facilities we developed and this wasn't
our idea we actually took it from
another Health Department uh feedback
report on antibiotic use because one of
the questions we often get from
facilities is I know what my S is but
how do I compare to other facilities
next slide and what we're able to do is
provide facilities with the plot which
shows them where their SAR Falls in
relation to other facilities in the
state and specifically to other
facilities that are similar whether
you're a critical access hospital or a
larger facility and what we've heard
from our facilities is when they find
out their SAR of 1.4 which they thought
wasn't that bad uh is the highest SAR in
the state they tend to reassess how
they're doing on antibiotic use and so
we think this data has been very useful
next
slide we go to the next
slide last is education there's lots of
ways to provide education I think again
you want to focus where the resources
are lacking next
slide we've developed a stewardship
website with many tools for acute care
long-term care ambulatory care we have a
YouTube uh site which uh a channel which
has numerous educational videos on it
next slide we've put on a Statewide
stewardship Summit uh since 2018 we
missed a year or two in there because of
covid been an in-person event you can
see from the map where people attended
in 2023 we've tried to cover a broad
swath of topics focusing on acute care
critical access but also including
long-term care in ambulatory settings
and trying to bring in some infection
control from our survey in 2023 we did a
follow-up survey at 6 months
what we found is that uh 83% of the
facilities that responded said they
implemented practice changes and over
half said that it improved patient
outcomes and three quarters said that it
improved team performance and so we're
very happy with this and we plan to
continue to do this because it seems our
facilities are finding it beneficial
next slide and so just to finish out I
think Health departments really are
uniquely position to interface with
various facilities particularly CL
critical access hospitals and really
promote the Improvement in care for our
patients in their health district and
with that we'll move on to the next
slide which I believe is the uh the
questions great thank you so much Angela
if you can advance to the next
slide I would like to thank our
presenters Amy and Anthony and Trevor
for highly informative and interesting
uh presentations on all the different
topics and I want to thank Amy she has
been actively answering questions in
written form and if there's any
additional questions regarding nhsn you
can contact the um their mail box and um
they can respond through email and then
I also uh just would really like to
thank you the audience in attending and
listening to this presentation and
celebrating us antibiotic awareness week
and National World Health day so thank
you so much for joining and uh once
again here is the CE
information Angela I think we can
you can stop the recording
